Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 13283-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#13283-1-AP, RRID:AB_2287290
- Product name
- TEAD1 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated TEAD1 antibody (Cat. #13283-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: WB, ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Role of Clostridium perfringens Enterotoxin on YAP Activation in Colonic Sessile Serrated Adenoma/ Polyps with Dysplasia.
Force-induced decline of TEA domain family member 1 contributes to osteoclastogenesis via regulation of Osteoprotegerin.
EGFR/c-myc axis regulates TGFβ/Hippo/Notch pathway via epigenetic silencing miR-524 in gliomas.
YAP1-TEAD1-Glut1 axis dictates the oncogenic phenotypes of breast cancer cells by modulating glycolysis.
siRNA targeting YAP gene inhibits gastric carcinoma growth and tumor metastasis in SCID mice.
YAP is overexpressed in clear cell renal cell carcinoma and its knockdown reduces cell proliferation and induces cell cycle arrest and apoptosis.
Fujiwara-Tani R, Fujii K, Mori S, Kishi S, Sasaki T, Ohmori H, Nakashima C, Kawahara I, Nishiguchi Y, Mori T, Sho M, Kondoh M, Luo Y, Kuniyasu H
International journal of molecular sciences 2020 May 28;21(11)
International journal of molecular sciences 2020 May 28;21(11)
Force-induced decline of TEA domain family member 1 contributes to osteoclastogenesis via regulation of Osteoprotegerin.
Li Q, Han G, Liu D, Zhou Y
Archives of oral biology 2019 Apr;100:23-32
Archives of oral biology 2019 Apr;100:23-32
EGFR/c-myc axis regulates TGFβ/Hippo/Notch pathway via epigenetic silencing miR-524 in gliomas.
Zhao K, Wang Q, Wang Y, Huang K, Yang C, Li Y, Yi K, Kang C
Cancer letters 2017 Oct 10;406:12-21
Cancer letters 2017 Oct 10;406:12-21
YAP1-TEAD1-Glut1 axis dictates the oncogenic phenotypes of breast cancer cells by modulating glycolysis.
Lin C, Xu X
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2017 Nov;95:789-794
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2017 Nov;95:789-794
siRNA targeting YAP gene inhibits gastric carcinoma growth and tumor metastasis in SCID mice.
Zhou Z, Zhu JS, Gao CP, Li LP, Zhou C, Wang H, Liu XG
Oncology letters 2016 Apr;11(4):2806-2814
Oncology letters 2016 Apr;11(4):2806-2814
YAP is overexpressed in clear cell renal cell carcinoma and its knockdown reduces cell proliferation and induces cell cycle arrest and apoptosis.
Cao JJ, Zhao XM, Wang DL, Chen KH, Sheng X, Li WB, Li MC, Liu WJ, He J
Oncology reports 2014 Oct;32(4):1594-600
Oncology reports 2014 Oct;32(4):1594-600
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The TEAD1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human TEAD1. This antibody recognizes human, mouse, rat antigen. The TEAD1 antibody has been validated for the following applications: ELISA, WB analysis.